SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Clinical trial NCT07198165 · RECRUITING

Trial details

NCT number: NCT07198165
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Rectal Adenocarcinoma Rectal Cancer, Radiotherapy Rectal Cancer Patients Immunotherapy Total Neoadjuvant Therapy Total Neoadjuvant Treatment Targeted Therapy Chemoradiotherapy

Start date: 2025-09-05
Primary completion: 2030-12-31
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.